Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Nanomaterials (Basel, Switzerland)|November 11, 2022
Diverse Pathways of Engineered Nanoparticle-Induced NLRP3 Inflammasome ActivationXin Liao, Yudong Liu, Jiarong Zheng, et al.Theranostics|January 2, 2025
Targeting cancer with precision: strategical insights into TCR-engineered T cell therapiesPei Lin, Yunfan Lin, Zizhao Mai, et al.Clinical and Translational Medicine|May 27, 2024
Decoding the ribosome's hidden language: rRNA modifications as key players in cancer dynamics and targeted therapiesLi Cui, Jiarong Zheng, Yunfan Lin, et al.Cell Death & Disease|October 27, 2024
Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironmentYucheng Zheng, Rongwei Xu, Xu Chen, et al.Medcomm|September 24, 2025
Advancements and Challenges in Salivary Metabolomics for Early Detection and Monitoring of Systemic DiseasesXinyuan Zhao, Xu Chen, Zihao Zhou, et al.International Journal of Biological Macromolecules|April 24, 2024
Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidenceLi Cui, Yucheng Zheng, Rongwei Xu, et al.Journal of Translational Medicine|March 23, 2023
The oral microbiome in autoimmune diseases: friend or foe?Xiaoyan Huang, Xiangyu Huang, Yi Huang, et al.CNS Neuroscience & Therapeutics|October 14, 2025
KIF4A Promotes Glioblastoma Malignant Progression and Transmission of Temozolomide Resistance in the Tumor Microenvironment via the HIF1A/VEGFA AxisXinan Shen, Honglei Cheng, Yihan Xia, et al.Experimental & Molecular Medicine|August 1, 2025
METTL1-driven epitranscriptomic enhancement of TXNDC12 boosts c-Myc stability through USP5 in HNSCCZizhao Mai, Jiarong Zheng, Ye Lu, et al.Materials Today. Bio|January 1, 2025
Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatmentsRongwei Xu, Pei Lin, Jiarong Zheng, et al.Pageof 4